Stephanie David - Publications

"Tumor Targeting, Imaging, RadiotherapieS" 17th edition of the workshop organized by the Cancéropôle Grand-Ouest, October 9-12, 2024, Erquy, France

Journal: Bulletin du cancer

Published: December 10, 2025

Autologous Production: The Future of Sustainable Antibody Treatments.

Journal: Human gene therapy

Published: June 30, 2025

Development of anti-EGFR targeted magnetic nanoparticles for doxorubicin delivery into triple negative breast cancer cells.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: June 19, 2025

In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.

Journal: International journal of pharmaceutics: X

Published: November 24, 2022

Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.

Journal: Pharmaceutics

Published: October 15, 2022

Smart PEG-Block-PLA/PLA Nanosystems: Impact of the Characteristics of the Polymer Blend on the Redox Responsiveness.

Journal: Materials (Basel, Switzerland)

Published: October 10, 2022

Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 16, 2022

Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.

Journal: International journal of pharmaceutics: X

Published: August 30, 2022

WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.

Journal: International journal of pharmaceutics

Published: March 02, 2022

Two-step formulation of magnetic nanoprobes for microRNA capture.

Journal: RSC advances

Published: December 13, 2021

Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: July 07, 2020

Homogeneous distribution of fatty ester-based active cosmetic ingredients in hydrophilic thin films by means of nanodispersion.

Journal: International journal of cosmetic science

Published: May 15, 2020